The addition of $2.25B in term debt to the medical-surgical subsidiary signals progress toward the planned spin-off from McKesson Corp (MCK). For MCK shareholders, this is a neutral operational step—leverage at the subsidiary increases but likely reflects the intended capital structure of the separated entity. Monitor the spin-off timeline and any credit rating actions on the subsidiary. The term loan's floating-rate exposure (SOFR+2.25%) creates modest interest cost sensitivity to Fed policy.
Price Chart
Executive Summary
McKesson Corp subsidiary McKesson Medical-Surgical Top Holdings Inc. amended its April 2026 credit agreement to add a $2.25 billion senior secured Term B loan due 2032, with JPMorgan as sole lender. Proceeds will fund transaction costs and the broader spin-off/restructuring (the 'Transactions'). The facility carries an interest rate of SOFR + 2.25% (Term Benchmark) or Base Rate + 1.25% and is secured by substantially all assets of the borrower and its material US subsidiaries. This is a significant increase in subsidiary-level leverage but appears to be a planned component of the medical-surgical business separation from McKesson Corp.
Key Financial Metrics
Key Facts
- $2.25 billion incremental senior secured Term B loan added to existing credit agreement for McKesson Medical-Surgical Top Holdings Inc.
- Loan matures in 2032 (sixth anniversary of June 9, 2026 closing) and is priced at SOFR + 2.25% per annum (or Base Rate + 1.25%)
- JPMorgan Chase Bank, N.A. is the sole Amendment No. 1 Term B Lender for this tranche
- Proceeds are stated to be used to pay fees/expenses of the amendment and to fund the 'Transactions'—likely including the planned spin-off of McKesson's medical-surgical business
- Credit agreement contains financial covenants: maximum total net leverage ratio and minimum interest coverage ratio, with customary cure rights
- Existing facilities under the same agreement: $750M Term A-1, $250M Term A-2, and $1.0B revolving credit facility remain in place
Financial Impact
Adds $2.25 billion in new senior secured term debt at the McKesson Medical-Surgical subsidiary, increasing total credit facility commitments under this agreement from ~$2.0 billion to ~$4.25 billion (including the undrawn revolver). Interest expense will increase by approximately SOFR + 2.25% on the drawn amount.
Risk Factors
- Subsidiary leverage rises significantly with $2.25B new secured debt, increasing financial risk at the spun-off entity
- Floating-rate exposure (SOFR + 2.25%) creates earnings sensitivity to interest rate increases
- Execution risk around the broader spin-off and use of proceeds if the Transactions are delayed or restructured
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000927653-26-000167 |
| Document: mck-20260609.htm | 0000927653-26-000167 |
| Document: 0000927653-26-000167-index-headers.html | 0000927653-26-000167 |
| Document: 0000927653-26-000167-index.html | 0000927653-26-000167 |
| Document: 0000927653-26-000167.txt | 0000927653-26-000167 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 28, 2026 4w ago | 8-K | $885.32 $851.02 | ▼ −3.87% | ▼ −3.93% | $894.46 (+1.03%) |
Jul 1, 2026 13w ago | 8-K | $768.06 $888.56 | ▲ +15.69% | ▲ +17.87% | $894.46 (+16.46%) |
Jun 30, 2026 13w ago | DEFA14A | $768.06 $888.56 | ▲ +15.69% | ▲ +17.87% | $894.46 (+16.46%) |
Jun 12, 2026 15w ago | DEFA14A | $779.78 $812.28 | ▲ +4.17% | ▲ +4.92% | $894.46 (+14.71%) |
Jun 12, 2026 16w ago | 8-K | $784.05 $805.96 | ▲ +2.79% | ▲ +1.01% | $894.46 (+14.08%) |
Jun 8, 2026 16w ago | Insider Cluster | $766.64 $784.23 | ▲ +2.29% | ▲ +0.66% | $894.46 (+16.67%) |
Jun 3, 2026 17w ago | Insider Cluster | $739.40 $768.06 | ▲ +3.88% | ▲ +5.00% | $894.46 (+20.97%) |
Jun 2, 2026 17w ago | Insider Cluster | $736.15 $768.06 | ▲ +4.34% | ▲ +6.15% | $894.46 (+21.51%) |
May 27, 2026 18w ago | Insider Cluster | $756.13 $766.55 | ▲ +1.38% | ▲ +3.67% | $894.46 (+18.29%) |
May 27, 2026 18w ago | Insider Cluster | $756.13 $766.55 | ▲ +1.38% | ▲ +3.67% | $894.46 (+18.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access